Product Information

TOPIRAMATE 200 MG TABLET is a generic product labeled by Exelan Pharmaceuticals Inc., priced at $0.1086 per EA under NDC 76282028160. Its NADAC has been published 311 times since Dec 9, 2020.

FDA first approved this application on Mar 27, 2009. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

TOPIRAMATE 200 MG TABLET

Topiramate
$0.1086per EA

Strength

200 mg/1

NDC

76282028160

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

TOPIRAMATE

Approval Type

Generic (ANDA)

FDA Application

ANDA079162

FDA Approved

3/27/2009

TE Code

AB

On Market Since

9/7/2020

Pharmacological Classes

Cytochrome P450 2C19 Inhibitors
Cytochrome P450 3A4 Inducers
Decreased Central Nervous System Disorganized Electrical Activity

Price Statistics

The NADAC for TOPIRAMATE 200 MG TABLET has been published 311 times since Dec 9, 2020, and over the history we have for it it has declined 15.7%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1086 per EA
All-time high$0.1300 (Jan 13, 2021)
All-time low$0.0880 (Apr 17, 2024)
52-week high$0.1102
52-week low$0.1041
Median price$0.1070
Average price$0.1079
Largest weekly change-19.3% (Apr 17, 2024)
Weeks tracked311
Tracking sinceDec 9, 2020

Price History

1W

-0.2%

1M

-1.4%

3M

-1.1%

6M

+1.9%

1Y

+7.1%

3Y

+10.8%

5Y

-3.0%

All

-15.7%

Generic Alternatives

The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 19% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of TOPIRAMATE 200 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for TOPIRAMATE 200 MG TABLET, manufactured by Exelan Pharmaceuticals Inc., is $0.1086 per EA (NDC 76282028160), effective Nov 18, 2026.

How has the price of TOPIRAMATE 200 MG TABLET changed over time?

Over the history we have for it, the NADAC for TOPIRAMATE 200 MG TABLET has declined 15.7%. It has been tracked across 311 weekly CMS publications since Dec 9, 2020.

What are the highest and lowest recorded NADAC prices for TOPIRAMATE 200 MG TABLET?

Since Dec 9, 2020, the NADAC for TOPIRAMATE 200 MG TABLET has ranged from a low of $0.0880 (Apr 17, 2024) to a high of $0.1300 (Jan 13, 2021), with a median of $0.1070 per EA.

Are there cheaper alternatives to TOPIRAMATE 200 MG TABLET?

Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TOPIRAMATE 200 MG TABLET, is $0.0880 per EA — about 19% below TOPIRAMATE 200 MG TABLET.

Who manufactures TOPIRAMATE 200 MG TABLET?

TOPIRAMATE 200 MG TABLET (NDC 76282028160) is labeled by Exelan Pharmaceuticals Inc., and CMS classifies it as a generic product.